Terns Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.

About TERN

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. 

CEO
Amy L. Burroughs
CEOAmy L. Burroughs
Employees
66
Employees66
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2017
Founded2017
Employees
66
Employees66

TERN Key Statistics

Market cap
596.12M
Market cap596.12M
Price-Earnings ratio
-5.29
Price-Earnings ratio-5.29
Dividend yield
Dividend yield
Average volume
1.41M
Average volume1.41M
High today
$7.34
High today$7.34
Low today
$6.71
Low today$6.71
Open price
$6.83
Open price$6.83
Volume
998.39K
Volume998.39K
52 Week high
$11.40
52 Week high$11.40
52 Week low
$3.26
52 Week low$3.26

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.